 Avadel Pharmaceuticals PLC NASDAQ: AVDL reported 1Q results and provided updated color on the U.S. marketing application for FT218. FT218 is once nightly sodium oxybate for narcolepsy, which would compete with Jazz Pharmaceuticals PLC NASDAQ: JAZZ twice-nightly franchise. 